This is consistent with previous results using TCGA and METABRIC datasets, where breast cancers arising from predominantly APOBEC3B deletion carriers of European descent were reported to be enriched for immune response-related gene sets [10]. This evidence concerns the gene APOBEC3B and breast cancer.